Acadia Healthcare Co Inc

ACHC

Equity

ISIN US00404A1097 / Valor 14151414

NASDAQ (2025-04-01)

USD 29.93-1.29%

Acadia Healthcare Co Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Acadia Healthcare Co Inc is a leading provider of behavioral healthcare services in the United States and Puerto Rico, operating 253 treatment facilities across 38 states. The company offers various levels of care for behavioral health and substance use disorders, including detoxification, residential treatment for addiction, acute psychiatric inpatient hospitalization, medication-assisted treatment services, and outpatient programming options. Acadia Healthcare aims to meet patients at different stages of their treatment process, providing a safe environment for individuals to receive the care they need. The company continues to expand its reach through the construction of new facilities, the acquisition of existing facilities, and partnerships with reputable organizations. With a focus on innovative, patient-centered approaches to treatment, Acadia Healthcare specializes in helping individuals of all ages who are struggling with mental health disorders and addiction.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

In the third quarter of 2024, Acadia Healthcare Co Inc reported a revenue of $815.6 million, marking an 8.7% increase compared to the same quarter in 2023. This growth was driven by an 8.6% rise in same facility revenue, which included a 3.6% increase in revenue per patient day and a 4.7% increase in patient days.

Net Income

Acadia Healthcare Co Inc's net income for the third quarter of 2024 was $68.1 million, translating to $0.74 per diluted share. The adjusted income, which excludes certain non-GAAP financial measures, was $84.1 million or $0.91 per diluted share, reflecting the company's strong financial performance during this period.

Adjusted EBITDA

The adjusted EBITDA for Acadia Healthcare Co Inc in the third quarter of 2024 was $194.3 million, representing a 10.5% increase over the third quarter of 2023. The same facility adjusted EBITDA margin also improved by 100 basis points to 29.7%, indicating enhanced operational efficiency.

Strategic Investments

During the third quarter of 2024, Acadia Healthcare Co Inc continued to focus on strategic growth by adding 15 beds to existing facilities and opening five new Comprehensive Treatment Centers (CTCs). The company now operates 164 CTCs across 32 states, treating over 72,000 patients daily, and is on track to open up to 14 new CTCs by the end of the year.

Financial Guidance

Acadia Healthcare Co Inc revised its financial guidance for 2024, projecting revenue between $3.150 to $3.165 billion and adjusted EBITDA between $725 to $735 million. The company anticipates adjusted earnings per diluted share to range from $3.35 to $3.45, reflecting its confidence in continued growth and operational success.

Summarized from source with an LLMView Source

Key figures

-60.7%1Y

-55.4%3Y

74.4%5Y

Performance

55.5%1Y

40.8%3Y

43.2%5Y

Volatility